Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Categories: Reuters


In story on experimental contraceptive gel, Reuters lets drug company control the narrative


Hard to find the journalism in this brief Reuters story on clinical trial results for psoriasis drug


Reuters rehashes Merck announcement on Keytruda trial for esophageal cancer


Litany of errors hampers Reuters story on experimental breast cancer drug


Reuters once again rehashes drug company news release


Reuters story on kidney cancer drug makes us ask: How is this journalism?


Reuters story on MS drug for kids even less informative than the FDA news release


Reuters numbs with numbers on experimental migraine drug


Reuters lets Roche make data-free claims about drug’s impact on lung cancer survival


How strong is the evidence behind FDA’s proposal to reduce nicotine levels in cigarettes? Reuters story doesn’t say